Atlas Trials

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients

Clinical trial NCT00526448 · UNKNOWN

Trial details

NCT number
NCT00526448
Sponsor
Hospital Carlos III, Madrid
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis C
Start date
2007-06-01
Enrollment
384

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.